Summary
African horse sickness (
AHS
) is an arboviral disease of equids transmitted by
Culicoides
biting midges. The virus is endemic in parts of sub‐Saharan Africa and official
AHS
disease‐free status can be obtained from the World Organization for Animal Health on fulfilment of a number of criteria.
AHS
is associated with case fatality rates of up to 95%, making an outbreak among naïve horses both a welfare and economic disaster. The worldwide distributions of similar vector‐borne diseases (particularly bluetongue disease of ruminants) are changing rapidly, probably due to a combination of globalisation and climate change. There is extensive evidence that the requisite conditions for an
AHS
epizootic currently exist in disease‐free countries. In particular, although the stringent regulations enforced upon competition horses make them extremely unlikely to redistribute the virus, there are great concerns over the effects of illegal equid movement. An outbreak of
AHS
in a disease free region would have catastrophic effects on equine welfare and industry, particularly for international events such as the Olympic Games. While many regions have contingency plans in place to manage an outbreak of
AHS
, further research is urgently required if the equine industry is to avoid or effectively contain an
AHS
epizootic in disease‐free regions. This review describes the key aspects of
AHS
as a global issue and discusses the evidence supporting concerns that an epizootic may occur in
AHS
free countries, the planned government responses, and the roles and responsibilities of equine veterinarians.